Tag Archives: British Hypertension Society

(more…)

Activities The Society has been instrumental in developing guidelines for the management of hypertension, which have been modified on a variety of occasions. In particular, we have interacted with the National Institute for Health and Clinical Excellence (NICE) on their last two guidelines. Both the BHS and NICE guidelines are looked upon as highly influential worldwide. We have also successfully lobbied Government in respect to reducing dietary salt in foodstuffs. It is likely that more stringent Quality Outcome Framework blood pressure treatment targets will be introduced next year as a direct result of the Society’s influence. BHS Member

Key new recommendations include the following: Diagnosis of primary hypertension should be confirmed using 24–hour ambulatory blood pressure monitoring, or home blood pressure monitoring, rather than be based solely on measurements of blood pressure taken in the clinic. This is to reduce the occurrence of white coat hypertension, which recent studies have suggested is causing the misdiagnosis of hypertension in up to a quarter of the 12 million patients currently labeled with the condition. For the treatment of hypertension, the guideline now recommends that calcium channel blockers (CCBs) should be the first choice of agent used in patien

No content available

No content available

No content available

No content available